Phase 1 study

Not yet recruiting Phase 1

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Not yet recruiting
Phase Phase 1
Sponsor Arovella Therapeutics Ltd
Registry number NCT07518329
Started 20 August 2026 Today 16 October 2026 Estimated completion 31 March 2030

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
St. Vincent's Hospital Sydney NSW Status not stated
Mater Misericordiae Ltd (MML) Brisbane QLD Status not stated
Royal Adelaide Hospital Adelaide SA Status not stated
The Alfred Hospital Melbourne VIC Status not stated
Epworth HealthCare Richmond VIC Status not stated

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 46

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Over 18 years old

* Confirmed Diagnoses of Confirmed diagnosis of CD19+ non-Hodgkins lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma, Chronic Lymphatic Leukemia or Hairy Cell Leukemia

* Life Expectancy greater than 3 months

* Adequate Hepatic and Renal Function

* Adequate Bone Marrow Function

* Adequate ECG Vales

* Agree to use appropriate contraception to avoid becoming pregnant for up to 12 months post treatment and agree not to donate sperm or ova for 12 months post treatment

Exclusion Criteria:

* Prior anti-CD1d monoclonal antibody treatment

* Prior allogeneic stem cell transplant except where the participant is greater than 100 days and does not have Graft Versus Host Disease (uncontrolled)

* Prior Organ Transplant

* Previous Malignancy in last 3 years that's active or been treated.

* Current central nervous system involvement by lymphoma or leukaemia

* Evidence of Cardiac Dysfunction

* Active Autoimmune disease requiring systemic immunosuppressive therapy within the past 6 months.

* Known active hepatitis B, hepatitis C or human immunodeficiency virus (HIV) infection.

* History of Graft Vs Host Disease Grade 2 to 4

* No active Graft Vs Host Disease following a minimum of 3 months withdrawal from all Graft Vs Host Disease treatments

* Must not have received systemic anti-cancer therapy for the underlying malignancy within 6 weeks prior to the start of conditioning chemotherapy on Day -6.

* Participants that have received autologous or allogenic CAR-T cell therapy within 3 months prior to commencing screening.

* Use of systemic corticosteroids within 15 days of commencement of conditioning chemotherapy on Day -6 or other immunosuppressive drugs within 30 days

* Recent major surgery (within 4 weeks prior to commencement of conditioning chemotherapy on Day -6) or planned major surgery within 8 weeks following ALA-101 infusion on Day 1.

* Active infection requiring intravenous antibiotic, antifungal, or antiviral medication or hospital admission within 10 days prior to commencement of conditioning chemotherapy on Day -6

* Severe (e.g., severe chronic obstructive pulmonary disease, severe Parkinson's disease) or poorly controlled (e.g., hypertension, diabetes, active inflammatory bowel disease) medical condition.

* Vaccinated with a live vaccine within 28 days prior to commencement of conditioning chemotherapy on Day -6 or planned live vaccination within 6 months following ALA-101 infusion.

Additional criteria apply.

Dates on the record

Started 20 August 2026
Estimated completion 31 March 2030
Registry last updated 6 August 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 6 August 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.